Choose another country or region to see content specific to your location
United States
Choose country or region
Continue
NVAX

Novavax Inc

Novavax Inc is a biotech firm that specializes in developing vaccines for infectious diseases. Their proprietary technology platform enables the swift production of vaccines using virus-like particles (VLPs). The company's primary focus is on creating a vaccine for respiratory syncytial virus (RSV), a common cause of respiratory illness in infants and the elderly. Novavax is also working on vaccines for seasonal influenza, Ebola, and COVID-19. Novavax has partnered with various organizations, including the Coalition for Epidemic Preparedness Innovations (CEPI) and the Bill and Melinda Gates Foundation. The company is headquartered in Gaithersburg, Maryland, with additional facilities in Europe and India. Novavax is dedicated to enhancing global health by providing safe and effective vaccines to prevent the spread of infectious diseases.

Instrument specification for Novavax Inc

Start trading now with fast account opening.

Sign-up now to trade the most active markets

Open account
Boasting over 20 years in the markets, leading analysis tools and thousands of satisfied clients, OANDA is proud to be an award-winning broker.
Get access to the most active of global markets with thousands of trading instruments at your fingertips, as well leading technical tools to assist in your analysis.
Trade without unnecessary costs and total pricing transparency - OANDA offers zero-commission on major instruments, transparent pricing.
Scroll to top